Is CBN legal in Estonia?

Formal status

Across the EU, CBN is treated the same way as CBD: cannabinoid-containing extracts of Cannabis sativa are unauthorised novel foods under Regulation (EU) 2015/2283, and no Union list authorisation exists in any member state.

Cannabinol is not scheduled in Estonia. There is no standalone entry for it in any of the six Estonian schedules, verified against the annex substituted in full with effect from 14 August 2026. One group entry needs reading carefully rather than at a glance: schedule VI lists semi-synthetic cannabinoids, described in the annex's own English column as cannabinol derivatives. That catches the semi-synthetic family Estonia also lists individually, such as HHC and its analogues, and does not reach naturally occurring cannabinol in a hemp extract, which is neither semi-synthetic nor a derivative.

CBN therefore takes its status in Estonia from the plant-material entry, as CBD does. That entry covers cannabis and its processing products including extracts, but carves out varieties on the EU common catalogue at up to 0.3 per cent THC, and the State Agency of Medicines reads the carve-out as carrying through to the extract.

What remains is food law: the Agriculture and Food Board holds that hemp extracts are prohibited novel foods and may not be marketed as food or as food supplements.

Do we sell here?

Yes, for now: Sleep spray, Sleep capsules.

Yes, we ship to Estonia.

Cannabinol is not a controlled substance in Estonia. It has no entry of its own in the Estonian schedules. There is a group entry covering semi-synthetic cannabinoids, which is aimed at laboratory-made compounds such as HHC rather than at the cannabinol that occurs naturally in hemp.

What applies to CBN is the same EU-wide novel food question that applies to CBD: hemp extracts cannot currently be sold as food or food supplements anywhere in the EU, because no company holds the authorisation that would allow it. Estonia's enforcement of that position has been directed at sellers within Estonia.

Our CBD page for Estonia sets out the fuller country picture.

Outlook

Nothing in Estonian law singles cannabinol out, and Estonia's cannabinoid attention is directed elsewhere - at semi-synthetic and novel cannabinoids, which it schedules individually and quickly. Naturally occurring CBN in a hemp extract is not part of that picture.

Its position follows the extract it arrives in, so the thing to watch is the EU novel food question rather than anything Estonian. Estonia's schedules are amended often, which is worth monitoring in itself, but the recent direction of travel has been to add synthetic compounds rather than to narrow the industrial hemp carve-out.

Timeline

April 2022

The Estonian Agriculture and Food Board announces that CBD-containing foods may not be sold as unauthorised novel foods, writes to every seller known to it, and states it may issue precepts backed by coercive penalties of up to 9,600 euros.

Põllumajandus- ja Toiduamet

August 2023

The food regulator states that prohibited CBD products continue to reach the Estonian market, mostly from third countries, and refers advertising concerns to the consumer protection authority; no seizures, fines or product counts are reported.

ERR

July 2025

The State Agency of Medicines publishes its current position that CBD is not itself a listed narcotic or psychotropic substance, and is treated as narcotic only where it has been extracted from narcotic cannabis, hemp on the EU common catalogue at up to 0.3% THC not being narcotic.

Ravimiamet

August 2026

The Tax and Customs Board reports 381 narcotics and psychotropics violations in postal and courier consignments in 2025 and 222 in the first half of 2026, names Spain among the main dispatch countries, and warns that ordering products marketed as legal elsewhere can expose the recipient to criminal liability.

ERR / Maksu- ja Tolliamet

August 2026

Estonia's narcotic and psychotropic substance schedules are replaced in full by a new annex, retaining the cannabis entry with its exemption for EU common catalogue varieties at up to 0.3% THC; neither cannabidiol nor cannabinol appears anywhere in the schedules.

Riigi Teataja, RT I, 11.08.2026, 9